middle.news
Cyclopharm Doubles US Technegas Sites, Eyes 300 Installations by 2026
1:13am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
Cyclopharm Doubles US Technegas Sites, Eyes 300 Installations by 2026
1:13am on Saturday 30th of August, 2025 AEST
Key Points
26% revenue growth to $15.42 million, led by US and Third-Party distribution sales
Net loss widened slightly to $7.69 million due to US expansion investments
US Technegas® sales doubled to $1.24 million; installations increased to 35 sites
Five-year US patent extension secured, protecting market exclusivity through 2031
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CYC
OPEN ARTICLE